ArticleJCEM case reports2026
Severe hyperandrogenism and mild autonomous cortisol secretion from a functional lipid-poor adrenal cortical adenoma.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 44-year-old woman presented with progressive hirsutism, deepening of voice, irregular menses, and left flank discomfort. Laboratory evaluation revealed markedly elevated serum testosterone and androstenedione levels, along with unsuppressed cortisol following an overnight 1 mg dexamethasone test. Notably, dehydroepiandrosterone sulfate (DHEA-S) levels remained within normal limits. Imaging identified a 4.2-cm heterogeneously enhancing left adrenal mass with a precontrast attenuation of 15 Hounsfield units, consistent with a lipid-poor lesion. 18F-fluorodeoxyglucose positron emission tomography-computed tomography demonstrated intensely avid uptake. Open adrenalectomy was performed, and final pathology confirmed a benign adrenocortical adenoma. Postoperatively, both testosterone and androstenedione levels normalized. The patient received temporary hydrocortisone replacement per our institution's protocol for treatment of presumed postoperative adrenal insufficiency, which was discontinued after biochemical recovery of endogenous cortisol production. This case highlights that not all androgen and cortisol co-secreting adrenal masses are malignant, and that preoperative normal DHEA-S levels do not exclude an underlying adrenal source of hyperandrogenism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.